Full Text View
Tabular View
No Study Results Posted
Related Studies
Brain Tissue Collection for Neuropathological Studies
This study is currently recruiting participants.
Study NCT00001260   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: October 27, 2009   History of Changes

November 3, 1999
October 27, 2009
May 1990
 
 
 
Complete list of historical versions of study NCT00001260 on ClinicalTrials.gov Archive Site
 
 
 
Brain Tissue Collection for Neuropathological Studies
Brain Procurement for the Neuropathology Section, CBDB

The purpose of this study is to collect and study the brain tissue of deceased individuals to learn more about the nervous system and mental disorders. Information gained from donated tissue may lead to better treatments and potential cures for nervous system and mental disorders.

This study will ask relatives of deceased individuals to donate the brains of their deceased relatives to allow further study of neurological and psychiatric disorders....

The knowledge of how affected tissue deviates from normal control tissue is an integral part of fully understanding a neurological or psychiatric disorder. The purpose of this protocol is to establish a coordinating program with the pathology departments of the Washington, D.C. and metropolitan area hospitals and local medical examiner's offices for the donation of brain tissue.

 
Observational
 
  • Bipolar Disorder
  • Depression
  • Anxiety Disorders
  • Schizophrenia
  • Tourette's Syndrome
  • Brain Diseases
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
2000
 
 
  • INCLUSION CRITERIA:

Brain tissue is needed from individuals suffering from a variety of neuropsychiatric disorders, especially schizophrenia, but also anxiety disorders, suicide, bipolar disorder, depression, Tourette's Syndrome, drug addictions (PCP, cocaine, alcohol, heroin or the like) and any form of dementia. In addition, brains from normal individuals without a history of neuropsychiatric disease will be needed for controls.

Both
 
Yes
Contact: Joel E. Kleinman, M.D. (301) 402-7909 kleinmaj@intra.nimh.nih.gov
United States
 
NCT00001260
 
900142, 90-M-0142
National Institute of Mental Health (NIMH)
 
 
National Institutes of Health Clinical Center (CC)
March 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP